News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
NIH Awards $15M+ to Baylor-Led Consortia Targeting Rare Bone and Metabolic Disorders
September 27, 2025 - Media Coverage
- Rare Diseases Clinical Research Network (RDCRN)
NIH Awards More Than $15 Million to Fund Two Rare Diseases Consortia
September 25, 2025 - Grantee/Partner News
- Rare Diseases Clinical Research Network (RDCRN)
Clinical Trial Readiness Grants Aim to Set the Stage for Rare Disease Clinical Trials
March 17, 2020 - NCATS News
- Genetic and Rare Diseases (GARD) Information Center
To close the gap between development of candidate interventions for rare diseases and clinical testing, NCATS and NICHD created rare-disease Clinical Trial Readiness grants. Funds support projects that collect data needed to move on to clinical trials.
Collaborative Approach Aids Development of Potential Blood Test for Use in Alzheimer’s, Rare Syndromes Diagnoses
March 2, 2020 - NCATS News
- Genetic and Rare Diseases (GARD) Information Center
Contributions from the NCATS-led Rare Diseases Clinical Research Network helped develop a new blood test that may make it easier to diagnose Alzheimer’s disease and rare neurodegenerative syndromes.
Working Together Is the Name of the Game at Rare Disease Day at NIH 2019
April 4, 2019 - NCATS News
Rare Disease Day at NIH, held on February 28, 2019, exemplifies NCATS’ approach to rare diseases research: involving patients as partners throughout the translational research process to ensure that research and interventions address patients’ needs.
New Method Could Help Find Potential Treatments for Rare Diseases
January 5, 2019 - NCATS News
- Preclinical Chemical Biology Laboratory
Scientists in NCATS’ Assay Development and Screening Technology Program are developing new methods for screening small molecules that could help researchers test possible drugs and develop new treatments for many diseases.